136 related articles for article (PubMed ID: 19744519)
1. Excess mortality, length of stay and cost attributable to candidaemia.
Hassan I; Powell G; Sidhu M; Hart WM; Denning DW
J Infect; 2009 Nov; 59(5):360-5. PubMed ID: 19744519
[TBL] [Abstract][Full Text] [Related]
2. Candidaemia: incidence, risk factors, characteristics and outcomes in immunocompetent critically ill patients.
Vardakas KZ; Michalopoulos A; Kiriakidou KG; Siampli EP; Samonis G; Falagas ME
Clin Microbiol Infect; 2009 Mar; 15(3):289-92. PubMed ID: 19154488
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcome for nosocomial breakthrough candidaemia.
Pasqualotto AC; Nedel WL; Machado TS; Severo LC
J Infect; 2006 Mar; 52(3):216-22. PubMed ID: 15936825
[TBL] [Abstract][Full Text] [Related]
4. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections.
Moran C; Grussemeyer CA; Spalding JR; Benjamin DK; Reed SD
Am J Infect Control; 2010 Feb; 38(1):78-80. PubMed ID: 19836856
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and outcome of Candida bloodstream infection in an intensive care unit in Hong Kong.
Yap HY; Kwok KM; Gomersall CD; Fung SC; Lam TC; Leung PN; Hui M; Joynt GM
Hong Kong Med J; 2009 Aug; 15(4):255-61. PubMed ID: 19652231
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance.
Morgan J; Meltzer MI; Plikaytis BD; Sofair AN; Huie-White S; Wilcox S; Harrison LH; Seaberg EC; Hajjeh RA; Teutsch SM
Infect Control Hosp Epidemiol; 2005 Jun; 26(6):540-7. PubMed ID: 16018429
[TBL] [Abstract][Full Text] [Related]
7. Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs.
Moran C; Grussemeyer CA; Spalding JR; Benjamin DK; Reed SD
Pediatr Infect Dis J; 2009 May; 28(5):433-5. PubMed ID: 19319021
[TBL] [Abstract][Full Text] [Related]
8. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
9. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality.
Weinberger M; Leibovici L; Perez S; Samra Z; Ostfeld I; Levi I; Bash E; Turner D; Goldschmied-Reouven A; Regev-Yochay G; Pitlik SD; Keller N
J Hosp Infect; 2005 Oct; 61(2):146-54. PubMed ID: 16009456
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.
Zaoutis TE; Argon J; Chu J; Berlin JA; Walsh TJ; Feudtner C
Clin Infect Dis; 2005 Nov; 41(9):1232-9. PubMed ID: 16206095
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
[TBL] [Abstract][Full Text] [Related]
13. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial candidaemia in children: results of a 9-year study.
Celebi S; Hacimustafaoglu M; Ozdemir O; Ozkaya G
Mycoses; 2008 May; 51(3):248-57. PubMed ID: 18399906
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for candidaemia in critically ill patients: a prospective surveillance study.
Jordà-Marcos R; Alvarez-Lerma F; Jurado M; Palomar M; Nolla-Salas J; León MA; León C;
Mycoses; 2007 Jul; 50(4):302-10. PubMed ID: 17576324
[TBL] [Abstract][Full Text] [Related]
16. Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Marriott DJ; Playford EG; Chen S; Slavin M; Nguyen Q; Ellis D; Sorrell TC;
Crit Care; 2009; 13(4):R115. PubMed ID: 19594912
[TBL] [Abstract][Full Text] [Related]
17. Duration and outcome of persistent candidaemia in newborn infants.
Levy I; Shalit I; Askenazi S; Klinger G; Sirota L; Linder N
Mycoses; 2006 May; 49(3):197-201. PubMed ID: 16681810
[TBL] [Abstract][Full Text] [Related]
18. Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors.
Boo TW; O'reilly B; O'leary J; Cryan B
Mycoses; 2005 Jul; 48(4):251-9. PubMed ID: 15982207
[TBL] [Abstract][Full Text] [Related]
19. Effects of candidaemia on outcome of burns.
Vinsonneau C; Benyamina M; Baixench MT; Stephanazzi J; Augris C; Grabar S; Paugam A; Wassermann D
Burns; 2009 Jun; 35(4):561-4. PubMed ID: 19272713
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial candidaemia in a Finnish tertiary care centre during 1987-2004.
Poikonen E; Lyytikäinen O; Anttila VJ; Kuusela P; Koukila-Kähkölä P; Ollgren J; Ruutu P
Scand J Infect Dis; 2009; 41(8):590-6. PubMed ID: 19488931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
